San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

New Co. Looks to Extend Our Expiration Dates

BIOTECH: Venter Envisions Shift to Preventive Medicine Through Genomics Research

San Diego super scientist J. Craig Venter has launched a new company, Human Longevity Inc., with an ambitious — albeit ambiguous — pursuit: make people live longer.

Celgene Support Gives Abide Therapeutics $50M

BIOTECH: Enzymes Are Targeted to Treat A Variety of Conditions

San Diego-based Abide Therapeutics Inc. has partnered with biotech titan Celgene Corp. to develop new drugs in inflammation and immunology, receiving $50 million upfront in the deal.

Tease photo

The Good, The Bad: The Generics

PHARMA: Patient Benefits, Patent Lawsuits Are All Part of the Mix

Adamis Pharmaceuticals Corp. stands unique among San Diego’s many drugmakers: It’s going generic.

Tandem Diabetes Reports Sales Boosts for Q4, 2013

Tandem Diabetes Care Inc. reported sales of $29 million for the year ended Dec. 31, 2013, compared with $2.5 million for 2012.

Scripps Health Breaks Ground on $175M Medical Office Building

Scripps Health broke ground on its new, $175 million medical office building at Scripps Memorial Hospital La Jolla – part of a $2 billion renovation plan for the campus.

Tease photo

Sequenom Announces Leadership Changes, New CEO

Genetic testing company Sequenom Inc. is shaking up its leadership with a number of internal promotions.

Acadia Prices Public Offering of Common Stock

Acadia Pharmaceuticals Inc. announced it plans to raise $182 million in a secondary public offering of its common stock, pricing 6.4 million shares at $28.50 apiece.

Tracon Receives $10M in Development Deal With Japanese Drugmaker

San Diego-based Tracon Pharmaceuticals Inc. has received $10 million upfront after entering a global development and commercialization deal with Japanese drugmaker Santen Pharmaceutical Co. Ltd.

J. Craig Venter Part of Team Launching Human Longevity Inc.

San Diego super-scientist J. Craig Venter has launched a new company, Human Longevity Inc. that aims to prolong the human lifespan through genomics and cell therapy-based diagnostics.

Tease photo

Connect Appoints New CEO

Connect, a San Diego life sciences and technology nonprofit, has appointed veteran health care and investment banking executive Greg McKee as its new CEO.

Tease photo

Cardium Enters Strategic Collaboration, Will Change Name

Cardium Therapeutics Inc. has entered a strategic collaboration and funding arrangement with Shanxi Taxus Pharmaceuticals Co. Ltd. of China to support the worldwide clinical and commercial development of San Diego-based Cardium’s regenerative medicine therapeutics products.

Acadia Plans $150M Secondary Stock Offering

Acadia Pharmaceuticals Inc. announced it plans to raise $150 million in a secondary public offering of its common stock, though it didn’t indicate how it might use the proceeds.

MEI Pharma’s Leukemia Drug Receives Orphan Status From FDA

MEI Pharma Inc.’s investigational drug Pracinostat for treating acute myeloid leukemia has been granted orphan drug designation by the U.S. Food and Drug Administration, the company announced.

Abide to Receive $50M Upfront in Collaboration with Celgene Corp.

Privately held Abide Therapeutics Inc. has partnered with biotech titan Celgene Corp. to develop new drugs in inflammation and immunology, receiving $50 million upfront in the deal.

Isis' Stock Drops After Company Reports Q4 Results

Isis Pharmaceuticals Inc.’s stock dropped nearly 10 percent following the announcement of its fourth quarter earnings, despite more than doubling its revenue for the quarter ended Dec. 31, 2013. The company’s net loss increased significantly, however.